title: Betaseron: a breakthrough treatment for multiple sclerosis.
abstract: Multiple sclerosis (MS) is the most common cause of disability in young adults; in Canada, it affects 1 in 1,000 people. A chronic and complicated demyelinating autoimmune disorder of the central nervous system, MS has no known cure. Indeed, there has been no effective treatment until recently.
authors.affiliation: Vancouver Hospital, B.C.
authors.forename: W
authors.initials: W
authors.lastname: Morrison
authors.forename: J
authors.initials: J
authors.lastname: Nelson
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D018450:Disease Progression; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D017410:Practice Guidelines as Topic
chemical_list: D000276:Adjuvants, Immunologic; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a